申请人:Boehringer Mannheim GmbH
公开号:US06121322A1
公开(公告)日:2000-09-19
The invention provides novel azulene derivatives of general formula I ##STR1## wherein R.sub.1 to R.sub.6 have the significance given in the description, as well as their tautomers, enantiomers, diastereomers, racemates and physiologically compatible salts or esters and substances which are hydrolyzed or metabolized in vivo to compounds of formula I. The invention is also concerned with a process and intermediates for the manufacture of the above compounds, pharmaceutical compositions which contain such compounds as well as the use of these compounds in the treatment of inflammatory conditions.
本发明提供了一般式I的新型蓝紫烯衍生物,其中R.sub.1至R.sub.6具有说明书中给出的意义,以及它们的互变异构体、对映异构体、非对映异构体、外消旋体和生理相容的盐或酯,以及在体内水解或代谢成式I化合物的物质。本发明还涉及制造上述化合物的过程和中间体、包含这些化合物的药物组合物以及这些化合物在治疗炎症状况中的使用。